Drugs / Ademethionine
last change Dec 2015 re-read 2 minutes ago

Ademethionine

Developed for
alcoholic hepatitis
Investigated by
Zhejiang Hisun Pharmaceutical Co. Ltd.

Trials 1 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02024295 Dec 2013 → Dec 2015 alcoholic hepatitis Zhejiang Hisun Pharmaceutical Co. Ltd. Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ademethionine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02024295
Route Intravenous “ademethionine 1000mg ivgtt qd for 2 weeks” NCT02024295